References
- (ATAGI) ATAGoI. The Australian immunisation handbook. 10th ed. (2015 update). Canberra: Australian Government Department of Health; 2015.
- Claessens A, Hamilton WL, Kekre M, et al. Generation of antigenic diversity in Plasmodium falciparum by structured rearrangement of Var genes during mitosis. Plos Genetics. 2014;10(12):e1004812.
- Kang J-M, Moon S-U, Kim J-Y, et al. Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar. Malar J. 2010;9:131.
- Kwong PD, Doyle ML, Casper DJ, et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature. 2002;420(6916):678–682.
- Dale JB, Penfound TA, Chiang EY, et al. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine. 2011;29(46):8175–8178.
- Good MF, Reiman JM, Rodriguez IB, et al. Cross-species malaria immunity induced by chemically attenuated parasites. J Clin Invest. 2013;123:3353–3362.
- Seder RA, Chang LJ, Enama ME, et al. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science. 2013;341(6152):1359–1365.
- Rao KV. Selection in a T-dependent primary humoral response: new insights from polypeptide models. APMIS. 1999;107(9):807–818.
- Pruksakorn S, Galbraith A, Houghten RA, et al. Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies. J Immunol. 1992;149(8):2729–2735.
- Brandt ER, Hayman WA, Currie B, et al. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology. 1996;89(3):331–337.
- Good MF, Pandey M, Batzloff MR, et al. Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci. Expert Rev Vaccines. 2015;14(11):1459–1470.
- Rathore D, Nagarkatti R, Jani D, et al. An immunologically cryptic epitope of Plasmodium falciparum circumsporozoite protein facilitates liver cell recognition and induces protective antibodies that block liver cell invasion. The Journal of Biological Chemistry. 2005;280(21):20524–20529.
- Paramithiotis E, Pinard M, Lawton T, et al. A prion protein epitope selective for the pathologically misfolded conformation. Nature Medicine. 2003;9(7):893–899.
- Zijlstra A, Testa JE, Quigley JP. Targeting the proteome/epitome, implementation of subtractive immunization. Biochem Biophys Res Commun. 2003;303(3):733–744.
- Jin M, Lang J, Shen ZQ, et al. A rapid subtractive immunization method to prepare discriminatory monoclonal antibodies for food E. coli O157: H7contamination. Plos One. 2012;7(2):e31352.
- Ditlev SB, Florea R, Nielsen MA, et al. Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA. Plos One. 2014;9(1):e84981.
- Henderson KA, Streltsov VA, Coley AM, et al. Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition. Structure. 2007;15(11):1452–1466.
- Ofek G, Guenaga FJ, Schief WR, et al. Elicitation of structure-specific antibodies by epitope scaffolds. Proc Natl Acad Sci U S A. 2010;107(42):17880–17887.
- Impagliazzo A, Milder F, Kuipers H, et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science. 2015;349(6254):1301–1306.